Gender‐specific association between preproendothelin‐1 genotype and reduction of systolic blood pressure during antihypertensive treatment‐‐‐results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA)
暂无分享,去创建一个
K. Michaëlsson | H. Melhus | L. Lind | A. Syvänen | P. Hallberg | T. Kahan | L. Kurland | F. Nyström | U. Liljedahl | K. Malmqvist | K. Öhman | J. Karlsson
[1] H. Melhus,et al. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial , 2002, Journal of hypertension.
[2] A. Vasku,et al. Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia. , 2002, Medical science monitor : international medical journal of experimental and clinical research.
[3] B. Lévy,et al. Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro , 2002, Hypertension.
[4] Y. Liu,et al. Selected contribution: Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans. , 2001, Journal of applied physiology.
[5] L. Beilin,et al. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy , 2001, Journal of hypertension.
[6] H. Melhus,et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients , 2001, Journal of hypertension.
[7] Z. Fortes,et al. Ovarian Hormones Modulate Endothelin-1 Vascular Reactivity and mRNA Expression in DOCA-Salt Hypertensive Rats , 2001, Hypertension.
[8] C. Held,et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan , 2001, Journal of hypertension.
[9] K. Polderman,et al. Modulation of plasma endothelin levels by the menstrual cycle. , 2000, Metabolism: clinical and experimental.
[10] A. Marette,et al. Gender differences in hemodynamic responses to endothelin-1. , 2000, Journal of cardiovascular pharmacology.
[11] S. Vanni,et al. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. , 1999, Circulation research.
[12] D. Arveiler,et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. , 1999, Hypertension.
[13] A. Ergul,et al. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. , 1998, The Journal of pharmacology and experimental therapeutics.
[14] H. Krum,et al. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. , 1998, The New England journal of medicine.
[15] V. Miller,et al. The Effect of Estrogen Replacement Therapy on Plasma Nitric Oxide and Endothelin-1 Levels in Postmenopausal Women , 1998, Annals of Internal Medicine.
[16] K. Chatterjee,et al. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. , 1997, Circulation.
[17] V. Miller,et al. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. , 1997, American journal of physiology. Heart and circulatory physiology.
[18] E. Schiffrin,et al. Enhanced expression of endothelin‐1 gene in resistance arteries in severe human essential hypertension , 1997, Journal of hypertension.
[19] K. Lamping,et al. Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. , 1996, The American journal of physiology.
[20] M. J. Ashby,et al. Expression of endothelin peptides and mRNA in the human heart. , 1996, Clinical science.
[21] J. Puolakka,et al. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. , 1995, The Journal of clinical endocrinology and metabolism.
[22] M. Polokoff,et al. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.
[23] S. Sasayama,et al. Endothelin-1-selective receptor in the arterial intima of patients with hypertension. , 1994, Hypertension.
[24] K. Polderman,et al. Influence of Sex Hormones on Plasma Endothelin Levels , 1993, Annals of Internal Medicine.
[25] A. Davenport,et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. , 1992, Circulation research.
[26] A Sajantila,et al. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. , 1993, American journal of human genetics.
[27] M. Shichiri,et al. Plasma endothelin levels in hypertension and chronic renal failure. , 1990, Hypertension.
[28] M. Yanagisawa,et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Kurihara,et al. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.